Need Help?

Predicting resistance to chemotherapy using chromosomal instability signatures

The aim of this study is to assess whether three chromosomal instability signature biomarkers are capable of predicting resistance to standard chemotherapies, namely platins, taxanes and anthracyclines. As part of this study we compiled a proof of principle cohort of ovarian cancers treated with these therapies, profiled using the Illumina TSO500 panel. Analysis of these data demonstrated that accurate biomarker calling can be computed from these gene panel data.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000001451 Illumina NovaSeq X 8
Publications Citations
Predicting resistance to chemotherapy using chromosomal instability signatures.
Nat Genet 57: 2025 1708-1717
1